会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Compositions and methods for treating pigmentary conditions and melanoma
    • 用于治疗色素病症和黑色素瘤的组合物和方法
    • US08946291B2
    • 2015-02-03
    • US13059219
    • 2008-08-15
    • Vincent J. HearingThierry Passeron
    • Vincent J. HearingThierry Passeron
    • A61K31/203A61K31/5575A61P35/00A61K38/17
    • A61K38/1709
    • A method of treating melanoma in a subject comprising administering an amount of SOX9 sufficient to treat melanoma is disclosed. A method of treating a hyperpigmentary condition in a subject comprising administering an amount of inhibitor of SOX9 activity sufficient to treat the condition is disclosed. A method of treating melanoma in a subject comprising administering an amount of SOX9 sufficient to treat melanoma is disclosed. A method of treating melanoma in a subject comprising increasing the amounts of retinoic acid and SOX9 in the subject by amounts sufficient to treat melanoma. A method of treating melanoma in a subject comprising administering an amount of prostaglandin D2 and retinoic acid sufficient to treat cancer is disclosed. A method of sensitizing a melanoma cell to RA comprising administering an amount of SOX9 sufficient to decrease PRAME expression is disclosed.
    • 公开了一种治疗受试者黑素瘤的方法,包括给予一定量的足以治疗黑素瘤的SOX9。 公开了治疗患者色素沉着过度症状的方法,包括给予一定量的足以治疗病症的SOX9活性抑制剂。 公开了一种治疗受试者黑素瘤的方法,包括给予一定量的足以治疗黑素瘤的SOX9。 一种治疗受试者黑素瘤的方法,其包括以足以治疗黑素瘤的量增加受试者中视黄酸和SOX9的量。 公开了一种治疗受试者黑色素瘤的方法,包括给予一定量的足以治疗癌症的前列腺素D2和视黄酸。 公开了一种使黑素瘤细胞对RA敏感的方法,包括给予一定量足以降低PRAME表达的SOX9。
    • 6. 发明申请
    • Compositions and Methods for Treating Pigmentary Conditions and Melanoma
    • 治疗色素条件和黑色素瘤的组合物和方法
    • US20110269691A1
    • 2011-11-03
    • US13059219
    • 2008-08-15
    • Vincent J. HearingThierry Passeron
    • Vincent J. HearingThierry Passeron
    • A61K38/17A61P17/00A61P35/00A61K31/5575C12Q1/02
    • A61K38/1709
    • A method of treating a hypopigmentary condition in a subject comprising administering to the subject an amount of SOX9 sufficient to treat melanoma is disclosed. The hypopigmentary condition can be a result of surgery, trauma or vitiligo. A method of treating a hyperpigmentary condition in a subject comprising administering to the subject an amount of inhibitor of SOX9 activity sufficient to treat melanoma is disclosed. A method of treating melanoma in a subject comprising administering to the subject an amount of SOX9 sufficient to treat melanoma is disclosed. A method of treating melanoma in a subject comprising increasing the amounts of retinoic acid and SOX9 in the subject by amounts sufficient to treat melanoma. A method of treating melanoma in a subject comprising administering to the subject an amount of prostaglandin D2 (PGD2) and retinoic acid (RA) sufficient to treat cancer. A method of sensitizing a melanoma cell to RA comprising administering to the subject an amount of SOX9 sufficient to decrease PRAME expression. A method of increasing p21 expression in a subject comprising administering to the subject an amount of SOX9 sufficient to increase p21 expression. Methods of screening for compounds that treat hypopigmentary conditions and/or melanoma are provided.
    • 公开了一种治疗受试者色素沉着状况的方法,包括对受试者施用足以治疗黑素瘤的量的SOX9。 色素沉着状况可能是手术,创伤或白癜风的结果。 公开了一种治疗受试者色素沉着过度症状的方法,包括给予受试者一定量的足以治疗黑素瘤的SOX9活性抑制剂。 公开了一种治疗受试者黑色素瘤的方法,其包括向受试者施用足以治疗黑素瘤的量的SOX9。 一种治疗受试者黑素瘤的方法,其包括以足以治疗黑素瘤的量增加受试者中视黄酸和SOX9的量。 一种治疗受试者中的黑素瘤的方法,其包括给予受试者一定量的足以治疗癌症的前列腺素D2(PGD2)和视黄酸(RA)。 一种使黑素瘤细胞对RA敏感的方法,包括向受试者施用足以降低PRAME表达的量的SOX9。 增加受试者中p21表达的方法,其包括向受试者施用足以增加p21表达的量的SOX9。 提供了筛选治疗色素缺乏症和/或黑素瘤的化合物的方法。